Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Do not exceed the recommended serving
CTA Request Quote or Add BPC-157 to Inquiry Use the product page as your reference point, then continue into quote review or the inquiry cart with the category, pack size, MOQ, and documentation context already aligned.
Always discuss medical weight-loss treatment with a qualified healthcare provider
Safety in patients with existing mild-moderate liver disease Correlation between weight loss and estimated liver fat reduction TRIUMPH-2 (Ongoing, Expected 2026) Primary Endpoints: Weight loss in diabetic patients HbA1c reduction Secondary Endpoints (Liver): Liver enzymes Metabolic markers Diabetic Population Note: Higher prevalence of MASLD/NASH (~40-50%), so liver benefits particularly important in this group
Many 503A pharmacies offer replacement protocols for damaged medication
US$ 25.74
US$ 21.86
US$ 21.98
US$ 22.34
US$ 24.75
US$ 26.25
